Moxisylyte hydrochloride (Thymoxamine hydrochloride)，又称盐酸莫西赛利，是一种竞争性去甲肾上腺素拮抗剂，优先作用于突触后alpha-1肾上腺素能受体，用于治疗脑血管疾病，不依赖于减少血管压力使大脑血管伸张。Moxisylyte是一种前体药物，在血浆中迅速转化为活性代谢物（Deacetylmoxislyte或DAM）。

参考文献

[1] Sakakibara R, et al. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J Auton Nerv Syst. 2000 Mar 15;79(2-3):191-5.

[2] Marquer C, et al. Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use inimpotence. Fundam Clin Pharmacol. 1998;12(4):377-87.

冰袋运输。粉末直接保存于-25~-15℃，有效期3年。建议溶解分装后于-25~-15℃干燥保存，避免反复冻融。